Further, we leverage functional dependency datasets and ex vivo experimentation on primary patient samples to elucidate potential IFNγ-associated dependencies and mechanisms of venetoclax resistance unique to AML. The gene discussed is IFNG; the disease is acute myeloid leukemia.